Considering the important role of TGFbeta-1 signaling in glioblastoma progression, the TGFbeta-induced expression of FAP opens an interesting possibility of evaluating these approaches for parallel therapeutic targeting of several cell subpopulations in glioblastoma. The gene discussed is FAP; the disease is glioblastoma.